DECA
Denali Capital Acquisition Corp - Ordinary Shares - Class A

79
Loading...
Loading...
Semnur Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative non-opioid pain management products for the treatment of acute and chronic pain. Its lead product candidate, SP-102, is a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe lumbosacral radicular pain. The company is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
2

Frequently Asked Questions

What is Market Cap of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 52-week high for Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 52-week low for Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is Semnur Pharmaceuticals Inc - Ordinary Shares - Class A stock price today?
What was Semnur Pharmaceuticals Inc - Ordinary Shares - Class A stock price yesterday?
What is the PE ratio of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the Price-to-Book ratio of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
What is the 50-day moving average of Semnur Pharmaceuticals Inc - Ordinary Shares - Class A?
How many employess does Semnur Pharmaceuticals Inc - Ordinary Shares - Class A has?

Latest DECA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.